Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 13 04:00PM ET
31.99
Dollar change
+0.20
Percentage change
0.63
%
IndexRUT P/E26.81 EPS (ttm)1.19 Insider Own0.92% Shs Outstand174.58M Perf Week-0.34%
Market Cap5.47B Forward P/E22.55 EPS next Y1.42 Insider Trans-7.37% Shs Float169.45M Perf Month4.37%
Income211.31M PEG2.68 EPS next Q0.31 Inst Own101.91% Short Float3.45% Perf Quarter14.62%
Sales4.59B P/S1.19 EPS this Y-17.11% Inst Trans3.14% Short Ratio3.84 Perf Half Y0.60%
Book/sh8.23 P/B3.89 EPS next Y15.64% ROA6.34% Short Interest5.85M Perf Year-7.49%
Cash/sh2.20 P/C14.52 EPS next 5Y10.00% ROE14.64% 52W Range26.11 - 35.24 Perf YTD-5.05%
Dividend Est.- P/FCF28.06 EPS past 5Y- ROI8.10% 52W High-9.22% Beta1.30
Dividend TTM- Quick Ratio1.36 Sales past 5Y17.51% Gross Margin20.25% 52W Low22.52% ATR (14)0.75
Dividend Ex-Date- Current Ratio1.77 EPS Y/Y TTM-9.30% Oper. Margin6.87% RSI (14)54.74 Volatility2.16% 2.04%
Employees5809 Debt/Eq0.87 Sales Y/Y TTM11.07% Profit Margin4.60% Recom1.00 Target Price39.43
Option/ShortYes / Yes LT Debt/Eq0.85 EPS Q/Q-51.73% Payout0.00% Rel Volume1.26 Prev Close31.79
Sales Surprise4.92% EPS Surprise9.09% Sales Q/Q14.79% EarningsJul 31 BMO Avg Volume1.52M Price31.99
SMA200.62% SMA504.42% SMA2003.29% Trades Volume1,914,424 Change0.63%
Date Action Analyst Rating Change Price Target Change
Jul-16-24Initiated JMP Securities Mkt Outperform $36
Feb-27-23Resumed Jefferies Buy $38
Jul-19-21Upgrade Goldman Neutral → Buy $20 → $25
Jan-22-21Initiated Deutsche Bank Buy $22
Jan-11-21Initiated JP Morgan Overweight $21
Dec-15-20Initiated Goldman Neutral $18
Jun-24-20Initiated BofA/Merrill Buy $18
Aug-01-24 09:40AM
05:24AM
02:02AM
Jul-31-24 08:20AM
07:20AM
07:00AM Loading…
07:00AM
Jul-22-24 08:28AM
Jul-17-24 05:26PM
Jul-08-24 04:05PM
Jun-28-24 08:03AM
Jun-27-24 02:14PM
02:03PM
Jun-26-24 10:12PM
Jun-03-24 12:00PM
May-16-24 05:23PM
04:05PM Loading…
04:05PM
Apr-29-24 04:05PM
Apr-26-24 12:00PM
09:40AM
Apr-25-24 11:27AM
Apr-24-24 03:49AM
03:03AM
Apr-23-24 11:54AM
08:33AM
08:19AM
08:15AM
07:15AM
07:00AM
Apr-22-24 12:10PM
Apr-16-24 10:00AM
04:05PM Loading…
Apr-04-24 04:05PM
Mar-26-24 05:25PM
Mar-14-24 07:14PM
05:04PM
04:58PM
04:25PM
Mar-07-24 10:07AM
Feb-23-24 12:34PM
Feb-22-24 11:53PM
08:20AM
07:31AM
07:24AM
07:00AM
Feb-02-24 06:10AM
Jan-22-24 04:05PM
Jan-08-24 07:00AM
Dec-19-23 05:14AM
Dec-11-23 04:05PM
Dec-06-23 04:11PM
Nov-07-23 04:05PM
Oct-26-23 09:35AM
Oct-25-23 10:27PM
07:05PM
09:56AM
08:15AM
07:08AM
07:00AM
Oct-20-23 11:47AM
Oct-18-23 12:04PM
Oct-16-23 02:53PM
Oct-02-23 05:56AM
Sep-29-23 03:59PM
08:19AM
Sep-28-23 08:26PM
Sep-27-23 09:24PM
04:05PM
Sep-15-23 09:18AM
Sep-12-23 08:32AM
Sep-08-23 06:23PM
Sep-05-23 07:54AM
Sep-01-23 11:19AM
Aug-31-23 05:00PM
11:40AM
03:34AM
Aug-28-23 09:59AM
Aug-18-23 07:39AM
Aug-14-23 07:03PM
Aug-11-23 09:39AM
Aug-10-23 12:20PM
10:12AM
Aug-03-23 08:06AM
Aug-02-23 07:53AM
07:37AM
Jul-28-23 12:00PM
Jul-27-23 08:25AM
07:20AM
07:00AM
Jul-25-23 05:36AM
Jul-19-23 11:40AM
Jul-06-23 11:22AM
08:00AM
Jun-30-23 01:04PM
Jun-28-23 09:21AM
Jun-27-23 08:18AM
Jun-26-23 01:39PM
09:04AM
08:57AM
08:44AM
Jun-21-23 08:00PM
Jun-11-23 03:45AM
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients' homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pate R CarterDirectorSep 03 '24Sale32.371,46547,42136,126Sep 05 04:21 PM
SHAPIRO MICHAEL H.Chief Financial OfficerAug 22 '24Option Exercise18.9723,217440,426270,534Aug 23 05:27 PM
SHAPIRO MICHAEL H.Chief Financial OfficerAug 22 '24Sale30.9523,217718,501247,317Aug 23 05:27 PM
BETTEN ELIZABETH QUADROSDirectorAug 21 '24Sale31.0947,5311,477,53021,339Aug 22 07:38 PM
SULLIVAN TIMOTHY PDirectorAug 22 '24Sale30.9147,2491,460,58920,814Aug 22 07:36 PM
SHAPIRO MICHAEL H.OfficerAug 22 '24Proposed Sale32.0023,217743,000Aug 22 12:55 PM
SULLIVAN TIMOTHY PDirectorAug 22 '24Proposed Sale31.0047,2491,464,719Aug 21 05:43 PM
BETTEN ELIZABETH QUADROSDirectorAug 21 '24Proposed Sale32.0047,5311,521,000Aug 21 01:36 PM
Bavaro MichaelChief Human Resources OfficerAug 15 '24Option Exercise24.935,765143,70349,193Aug 19 04:23 PM
Bavaro MichaelChief Human Resources OfficerAug 15 '24Sale31.425,765181,13643,428Aug 19 04:23 PM
Bavaro MichaelOfficerAug 15 '24Proposed Sale32.005,765184,480Aug 15 12:56 PM
Smyser CollinGC & Corporate SecretaryMay 19 '24Option Exercise0.00812042,120May 21 04:52 PM
Bavaro MichaelChief Human Resources OfficerFeb 28 '24Sale31.731,98462,94443,428Mar 01 04:28 PM
KRAEMER HARRY M JANSEN JRDirectorFeb 26 '24Buy31.5535,0001,104,352269,528Feb 28 04:41 PM
RADEMACHER JOHN CHARLESChief Executive OfficerFeb 21 '24Option Exercise0.0011,0870705,876Feb 23 06:21 PM
SHAPIRO MICHAEL H.Chief Financial OfficerFeb 17 '24Option Exercise0.003,6520180,570Feb 21 09:55 PM
Bierbower Elizabeth DDirectorOct 30 '23Buy26.373,00079,11013,515Nov 01 05:09 PM